Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3886

Alzheon’s amyloid-targeting pill fails another Alzheimer’s Phase 3

$
0
0
Alzheon’s controversial, decade-long bet that a failed Alzheimer’s drug could offer bigger benefits to a subset of patients at the highest risk for the disease has ended in another disappointment. On Thursday, the Framingham, MA ...

Viewing all articles
Browse latest Browse all 3886